Hancock Whitney’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Hancock Whitney's NVO Position: Q1 2026 in Review
Hancock Whitney sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 5,340 shares — an estimated $272K sold.
Hancock Whitney first reported a position in NVO in Q2 2014 and held it in 18 quarters. The position peaked at $853K in Q2 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Hancock Whitney reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- Hancock Whitney sold 5,340 Novo Nordisk shares in Q1 2026, an estimated $272K.
- Hancock Whitney first reported a position in Novo Nordisk in Q2 2014 and held it in 18 quarters.
- Hancock Whitney's Novo Nordisk position peaked at $853K in Q2 2024.
- 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Hancock Whitney's 13F filing for Q1 2026, filed 15 May 2026.